The most talked about and market moving research calls around Wall Street are now in one place.
Here are today’s research calls that investors need to know, as compiled by The Fly
Top 5 Upgrades: – Morgan Stanley upgraded Dell Technologies (DELL) to Equal Weight from Underweight with a price target of $448, up from $170. The company’s Q1 earnings report and a visit to Taiwan last week indicate Dell is managing the current semiconductor supply chain shortage better than peers, the firm tells investors in a research note. – Guggenheim upgraded Zscaler (ZS) to Buy from Neutral with a $214 price target. While this is a “trust me story,” the valuation here presents an opportunity to buy a category leader of a still nascent and hyper growth market, the firm tells investors in a research note. – Citi upgraded Kohl’s (KSS) to Buy from Neutral with a price target of $22, up from $14.
The firm cites valuation for the upgrade, saying the market is “too bearish” on the company’s free cash flow. – Wells Fargo upgraded Tandem Diabetes (TNDM) to Overweight from Equal Weight with a price target of $27, up from $21. The company’s pharmacy model is “transformational and de-risking faster” than expected, the firm says, adding that Tandem’s pay-as-you-go is tracking better than expected. – Mizuho upgraded Federal Realty (FRT) to Outperform from Neutral with a price target of $130, up from $121. The company is entering a new growth cycle, the firm says.